Current Size: 100%
Age-specific survival
Cancer | Years | Method | Sex | Age | Survived | Net survival | 95% lower | 95% upper |
---|---|---|---|---|---|---|---|---|
Bladder all | 2004-2008 | cohort | Both | 15-44 | 1.00 years | 92.6% | 87.9% | 97.7% |
Bladder all | 2004-2008 | cohort | Both | 15-44 | 5.00 years | 84.6% | 78.0% | 91.7% |
Bladder all | 2004-2008 | cohort | Both | 15-44 | 10.00 years | 83.8% | 77.0% | 91.1% |
Bladder all | 2004-2008 | cohort | Both | 45-54 | 1.00 years | 94.7% | 91.7% | 97.7% |
Bladder all | 2004-2008 | cohort | Both | 45-54 | 5.00 years | 86.9% | 82.4% | 91.6% |
Bladder all | 2004-2008 | cohort | Both | 45-54 | 10.00 years | 82.9% | 76.6% | 89.6% |
Bladder all | 2004-2008 | cohort | Both | 55-64 | 1.00 years | 93.8% | 91.6% | 96.0% |
Bladder all | 2004-2008 | cohort | Both | 55-64 | 5.00 years | 81.4% | 77.7% | 85.2% |
Bladder all | 2004-2008 | cohort | Both | 55-64 | 10.00 years | 76.0% | 71.0% | 81.4% |
Bladder all | 2004-2008 | cohort | Both | 65-74 | 1.00 years | 87.4% | 85.0% | 89.9% |
Bladder all | 2004-2008 | cohort | Both | 65-74 | 5.00 years | 76.6% | 73.0% | 80.4% |
Bladder all | 2004-2008 | cohort | Both | 65-74 | 10.00 years | 62.7% | 56.9% | 69.0% |
Bladder all | 2004-2008 | cohort | Both | 75-99 | 1.00 years | 72.5% | 69.5% | 75.6% |
Bladder all | 2004-2008 | cohort | Both | 75-99 | 5.00 years | 52.9% | 48.4% | 57.7% |
Bladder all | 2004-2008 | cohort | Both | 75-99 | 10.00 years | 43.6% | 32.8% | 58.0% |